Influencing Factors Investigation and In vitro Biological Performance Characterization of Nano β-TCP Synthesized via Microwave-ultrasonic-hydrothermal Multifield Coupling
Jing Luo , Zhi Li , Bowen Zhang , Bo Cheng , Jing Yang , Binbin Li , Xinyu Wang
Journal of Wuhan University of Technology Materials Science Edition ›› 2025, Vol. 40 ›› Issue (6) : 1795 -1810.
This study employed a microwave-ultrasonic-hydrothermal multifield coupling method to synthesize nano β-Tricalcium phosphate (β-TCP) powder, systematically evaluating the impact of various parameters, including reaction temperature, time, sintering temperature, reactant types and concentrations, and graphene oxide (GO) concentration, on the physicochemical properties of the nano β-TCP powder. The synthesized powder was characterized using X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), high-resolution transmission electron microscopy (HRTEM), inductively coupled plasma optical emission spectroscopy (ICP-OES), and thermogravimetric-differential scanning calorimetry (TG-DSC). The experimental results indicate that the optimal synthesis conditions are achieved with a 0.6 mol/L Ca(NO3)2·4H2O solution and a 0.4 mol/L (NH4)2HPO4 solution at a reaction temperature of 35 °C for 40 minutes, followed by sintering at 720 °C for 2 hours with 1×10−1g/L GO. The prepared β-TCP powder exhibits high crystallinity, a pure phase, good dispersibility, no significant aggregation, and uniform particle size of 59.75±12.84 nm. In vitro cytotoxicity tests show excellent biocompatibility and no cytotoxic effects on bone marrow stromal cells (BMSCs) even at concentrations up to 0.8 mg/mL. Furthermore, results from live-dead staining and nuclear membrane staining of cells co-cultured with the material demonstrate that the β-TCP can promote the proliferation and differentiation of BMSCs to a certain extent, highlighting its potential as a safe and effective material for bone tissue engineering.
nanoparticles / β-TCP / microwave-ultrasonic-hydrothermal / biomaterials / in vitro
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
Wuhan University of Technology and Springer-Verlag GmbH Germany, Part of Springer Nature
/
| 〈 |
|
〉 |